Company Performance Metrics
- Rahul Singh: DirectorPast Role: MeFy Care Private Limited, Co-Founder
At Sciverse, we are reshaping the future of diagnostics by developing intelligent point-of-care testing (POCT) platforms that seamlessly integrate artificial intelligence, microfluidics, photonics, and full-stack software engineering. Our mission is simple yet bold: to bring sophisticated diagnostic capabilities directly to patients and clinicians,
wherever they are. We focus on creating compact, portable diagnostic systems that enable lab-quality testing at the point of care, dramatically reducing time to diagnosis and improving patient outcomes. By combining advanced biosensors with precision microfluidics, we build highly sensitive platforms that are robust, reliable, and remarkably easy to use. Our AI-driven software—spanning computer vision pipelines for cellular analysis, cloud-connected health platforms, and mobile diagnostic applications—translates complex data into actionable clinical insights.
We also partner with medtech and biotech leaders around the world to deliver custom OEM solutions that merge specialized hardware, AI models, and regulatory-ready software into seamless, turnkey offerings.
Our portfolio includes MyCount XpressCBC, an AI-powered 5-part CBC analyzer that brings decentralized hematology testing to clinics, outreach programs, and emergency settings, and SciVision.ai, a transformative AI microscopy platform that turns any standard microscope into a smart diagnostic tool with automated image quantification and reporting.
Backed by a multidisciplinary team of engineers, scientists, and healthcare experts, we are committed to building products that exceed the highest standards of accuracy, usability, and compliance. At Sciverse, we believe the future of healthcare is decentralized, data-driven, and deeply human—and we’re building that future, one diagnostic platform at a time.